Enlarging parietal mass with lytic skull lesion.
Ching
Natascha
N
Division of Pediatric Infectious Diseases, Mattel Children's Hospital at University of California, Los Angeles, David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
Lasky
Joseph
J
Lazareff
Jorge
J
Moore
Theodore B
TB
Nielsen
Karin
K
D000293:Adolescent; D000900:Anti-Bacterial Agents; D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D003399:Craniotomy / Q000379:methods; D003453:Cryptococcosis / Q000175:diagnosis* / Q000628:therapy; D003455:Cryptococcus neoformans / Q000302:isolation & purification*; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D010019:Osteomyelitis / Q000175:diagnosis* / Q000628:therapy; D010294:Parietal Bone; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000276:immunology*; D018570:Risk Assessment; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents